Additionally, in patients classified by age, gender, race, smoking status, nodal metastasis status, tumor grade, individual cancer stage, and TP53 mutation, NUBPL DNA methylation levels were further reduced (Supplementary Figure 11B). The gene discussed is TP53; the disease is cancer.